Herbert Irving Comprehensive Cancer Center
Investigator
Joseph Jurcic, MD
Phone
646-317-5077
Email
jgj2110@cumc.columbia.edu

Dr. Joseph Jurcic is Professor of Medicine at Columbia University Medical Center and Director of the Hematologic Malignancies Section of the Division of Hematology/Oncology. His main focus is the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndrome. Research interests include acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy for leukemia, the development of novel small molecule inhibitors for leukemia, and the molecular monitoring of minimal residual disease.

He is the 2001 recipient of the Louis and Allston Boyer Young Investigator Award for Distinguished Achievement in Biomedical Research from Memorial Sloan-Kettering Cancer Center. He is author or coauthor of more than 80 articles and book chapters, has been the principal investigator on over 25 clinical trials, and regularly lectures at national and international meetings. He serves as a Leukemia Section Editor for The Oncologist. Prior to joining the faculty at Columbia University Medical Center, he was an Attending Physician on the Leukemia Service at Memorial Sloan-Kettering Cancer Center for over 18 years.


Clinical Studies Managed By This Investigator:
Condition Study Title
Leukemia [ CLOSED ] A study for patients with Acute Myelogenous Leukemia using study drug ABT-199
Leukemia [ CLOSED ] A study for subjects with acute myeloid leukemia in complete remission using study drug Azacitidine
Leukemia [ CLOSED ] A study for patients with newly diagnosed Acute Myeloid Leukemia (AML) using study drug ASP2215
Leukemia [ CLOSED ] A study for patients with myelodysplastic syndrome or chronic myelomonocytic leukemia using study drug birinapant
Leukemia [ CLOSED ] A study for patients with acute myeloid leukemia (AML) using study drugs Cytarabine and Lintuzumab-Actinium-225
Leukemia [ CLOSED ] A study for patients with Acute Myeloid Leukemia (AML) using study drug ASP2215
Blood Disorders [ CLOSED ] A study for patients with Myelodysplastic Syndrome (MDS) using study drug Vadastuximab Talirine
Leukemia [ CLOSED ] A study for patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome using study drugs FT 2102
Blood Disorders [ CLOSED ] Anemia due to Myelodysplastic syndromes (MDS) using study drug luspatercept
Blood Disorders [ CLOSED ] A study for patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) using study drug SY-1425
Leukemia [ CLOSED ] A study for patients with Acute Myeloid Leukemia (AML) using study drug atezolizumab and guadecitabine
Blood Disorders [ CLOSED ] A study for patients with myelodysplastic syndrome (MDS) using study drug venetoclax
Blood Disorders [ CLOSED ] A study for patients with Myelodysplastic Syndromes (MDS) using study drug Venetoclax
Leukemia [ CLOSED ] Study of Investigational New Drug in Subjects with Myelodysplastic Syndromes
Leukemia [ CLOSED ] Study of Experimental Drug in Patients with Acute Myeloid Leukemia (AML)
Leukemia [ CLOSED ] Study of Avapritinib (BLU-285) in Patients with Advanced Systemic Mastocytosis
Leukemia [ CLOSED ] Study of ASP2215 (Gilteritinib) Combined with Atezolizumab in Patients with Acute Myeloid Leukemia (AML) with FLT3 Gene Mutations
Leukemia [ CLOSED ] Study of PTC299 in Relapsed/Refractory Acute Leukemias
Leukemia [ CLOSED ] A Study of CYNK-001 in Adults with Newly Diagnosed Acute Myeloid Leukemia
Leukemia [ CLOSED ] Study of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Leukemia [ CLOSED ] Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) (ENHANCE)
Leukemia [ CLOSED ] Study of Fedratinib in Combination with Chemotherapy in Patients with Myeloproliferative Neoplasm (MPN) in Accelerated and Blast Phase
Cancer [ CLOSED ] Study of ISIS 702843 in Patients with Phlebotomy-Dependent Polycythemia Vera (PD-PV)
Leukemia Study of Drug - DSP-5336 in Patients with Leukemia
Leukemia [ CLOSED ] Study of Magrolimab in Combination with Chemotherapy in Patients with Acute Myeloid Leukemia (AML)
Leukemia [ CLOSED ] Study of Etavopivat in Patients with Myelodysplastic Syndromes (MDS)